Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dasan E&T; Co., Ltd.
WARNING LETTER
•Dasan E&T; Co., Ltd.•January 26, 2017

Dasan E&T; Co., Ltd. – FDA Warning Letter, Jan 26, 2017

Record Details

The FDA issued a Warning Letter to Dasan E&T Co., Ltd. following a January 23-26, 2017 inspection, citing significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Failure to test drug products prior to release (21 CFR 211.165(a))**: The firm released products without testing active ingredient identity and strength, and conformance with established levels of certain components. The provided response was inadequate due to a lack of specific details on testing attributes and methods. 2. **Inadequate laboratory controls (21 CFR 211.160(b))**: The firm failed to demonstrate the suitability of microbial limits test methods for their drug products. The response lacked sufficient detail or evidence of corrective actions. 3. **Failure to establish written procedures for production and process control (21 CFR 211.100(a))**: The firm had not validated manufacturing processes for drug products or their water system, which is used in drug products. Insufficient testing of the water system was also noted. The response was inadequate due to a lack of detail and evidence. 4. **Failure to conduct adequate testing of components (21 CFR 211.84(d)(1))**: The firm did not test glycerin raw material for diethylene

Company
Dasan E&T; Co., Ltd.
Inspection date
January 26, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 06ade7ae-881a-4de9-8e6d-c64acf26ba97

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.165(a)21 CFR 211.160(b)21 CFR 211.100(a)21 CFR 211.84(d)(1)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dasan E&T; Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.